Precision Bioscienes Inc.'s motion for a protective order, in competitor Cellectis SA’s action for the infringement of two patents titled “Nucelotide Sequence Encoding the Enzyme I-Scel and the Uses Thereof,” was granted by a federal district court in North Carolina. The court declined to impose the prosecution bar sought by Cellectis in its proposed protective order — that is, that attorneys who view information designated by Cellectis as highly confidential are barred from prosecuting patents related to the subject matter of the patents at issue for two years after the final resolution of this case. The court noted that there ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.